Home/Filings/4/0000899243-22-004826
4//SEC Filing

Beaulieu Joseph 4

Accession 0000899243-22-004826

CIK 0001571498other

Filed

Feb 3, 7:00 PM ET

Accepted

Feb 4, 4:15 PM ET

Size

5.4 KB

Accession

0000899243-22-004826

Insider Transaction Report

Form 4
Period: 2022-02-02
Beaulieu Joseph
Corporate Controller
Transactions
  • Sale

    Common Stock, par value $0.0001

    2022-02-02$1.37/sh687$94128,854 total
Footnotes (2)
  • [F1]Represents shares of Common Stock automatically sold by the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted under the Company's 2013 Stock Incentive Plan on February 1, 2021. The automatic sale of the reporting person's shares of Common Stock is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the reporting person.
  • [F2]The reporting person acquired 1,277 shares of Common Stock under the Company's 2013 Employee Stock Purchase Plan on August 31, 2021.

Issuer

Epizyme, Inc.

CIK 0001571498

Entity typeother

Related Parties

1
  • filerCIK 0001766032

Filing Metadata

Form type
4
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 4:15 PM ET
Size
5.4 KB